Hap Trading, LLC Atossa Therapeutics, Inc. Put Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.14 $4,346 - $6,041	-5,300 Reduced 27.89%	13,700 $26,000
Q2 2022 Aug 12, 2022	SELL	$0.85 - $1.28 $850 - $1,280	-1,000 Reduced 5.0%	19,000 $29,000
Q1 2022 May 12, 2022	SELL	$1.11 - $1.74 $5,217 - $8,178	-4,700 Reduced 19.03%	20,000 $27,000
Q4 2021 Feb 14, 2022	BUY	$1.6 - $3.27 $5,920 - $12,099	3,700 Added 17.62%	24,700 $41,000
Q3 2021 Nov 10, 2021	SELL	$2.89 - $6.4 $108,664 - $240,640	-37,600 Reduced 64.16%	21,000 $29,000
Q2 2021 Aug 11, 2021	BUY	$1.52 - $8.62 $71,744 - $406,863	47,200 Added 414.04%	58,600 $80,000
Q1 2021 May 14, 2021	BUY	$0.92 - $4.33 $10,488 - $49,362	11,400 New	11,400 $7,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.